Recovery of full donor chimerism with ibrutinib therapy in relapsed <scp>CLL</scp> after allogeneic stem cell transplantation

Quinquenel, Anne; Sicre de Fontbrune, Flore; Durot, Éric; Pannetier, Mélanie; Michonneau, David; Socié, Gèrard; Delmer, Alain; Peffault de Latour, Régis

doi:10.1111/bjh.14029

Public

Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation

Published in British Journal of Haematology • Mar 15, 2016

Authors:

Anne Quinquenel

Flore Sicre de Fontbrune

Éric Durot

Abstract

The prognosis of patients with chronic lymphocytic leukaemia (CLL) is highly variable, from a normal life span without any treatment to short survival after several lines of therapy. For eligible patients with high risk or refractory CLL, allogeneic haematopoietic stem cell transplantation (HSCT) ha...

Subject

Ibrutinib

Medicine

Transplantation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!